United Health Products, Inc. (UEEC)
USD 0.25
(-2.0%)
USD 0.25
(-2.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.42 Million USD | -11.12% |
| 2022 | 2.82 Million USD | -90.53% |
| 2021 | 29.8 Million USD | 100.69% |
| 2020 | 14.84 Million USD | 143.52% |
| 2019 | 6.09 Million USD | 162.07% |
| 2018 | 2.32 Million USD | 79.26% |
| 2017 | 1.29 Million USD | 102.32% |
| 2016 | 641.55 Thousand USD | -75.41% |
| 2015 | 2.6 Million USD | 20.1% |
| 2014 | 2.17 Million USD | 64.57% |
| 2013 | 1.31 Million USD | 537.51% |
| 2012 | 207.01 Thousand USD | -84.29% |
| 2011 | 1.31 Million USD | -50.23% |
| 2010 | 2.64 Million USD | 392.89% |
| 2009 | 537.05 Thousand USD | 88.52% |
| 2008 | 284.87 Thousand USD | 24.8% |
| 2007 | 228.26 Thousand USD | 19.41% |
| 2006 | 191.16 Thousand USD | 1133.21% |
| 2005 | 15.5 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 423.73 Thousand USD | -4.82% |
| 2024 Q2 | 403.93 Thousand USD | -4.38% |
| 2023 FY | 2.42 Million USD | -14.15% |
| 2023 Q1 | 1.05 Million USD | 90.4% |
| 2023 Q2 | 475.45 Thousand USD | -54.89% |
| 2023 Q3 | 450.45 Thousand USD | -5.26% |
| 2023 Q4 | 445.18 Thousand USD | -1.17% |
| 2022 Q4 | 553.56 Thousand USD | -0.8% |
| 2022 Q1 | 954.5 Thousand USD | -10.87% |
| 2022 Q2 | 754.79 Thousand USD | -20.92% |
| 2022 Q3 | 558.03 Thousand USD | -26.07% |
| 2022 FY | 2.82 Million USD | -90.53% |
| 2021 Q1 | 26.7 Million USD | 497.27% |
| 2021 FY | 29.8 Million USD | 100.69% |
| 2021 Q4 | 1.07 Million USD | 47.84% |
| 2021 Q3 | 724.41 Thousand USD | -44.28% |
| 2021 Q2 | 1.3 Million USD | -95.13% |
| 2020 FY | 14.84 Million USD | 143.52% |
| 2020 Q4 | 4.47 Million USD | -50.9% |
| 2020 Q3 | 9.1 Million USD | 1305.33% |
| 2020 Q2 | 647.95 Thousand USD | 3.84% |
| 2020 Q1 | 623.99 Thousand USD | -70.34% |
| 2019 FY | 6.09 Million USD | 162.07% |
| 2019 Q1 | 2.98 Million USD | 376.76% |
| 2019 Q4 | 2.1 Million USD | 381.81% |
| 2019 Q3 | 436.66 Thousand USD | -23.56% |
| 2019 Q2 | 571.23 Thousand USD | -80.87% |
| 2018 FY | 2.32 Million USD | 79.26% |
| 2018 Q4 | 626.28 Thousand USD | 55.27% |
| 2018 Q1 | 378.59 Thousand USD | -54.77% |
| 2018 Q2 | 918.49 Thousand USD | 142.61% |
| 2018 Q3 | 403.35 Thousand USD | -56.08% |
| 2017 Q4 | 837.09 Thousand USD | 360.41% |
| 2017 Q3 | 181.81 Thousand USD | 40.63% |
| 2017 Q2 | 129.29 Thousand USD | -13.66% |
| 2017 FY | 1.29 Million USD | 102.32% |
| 2017 Q1 | 149.75 Thousand USD | -43.76% |
| 2016 Q1 | 126.47 Thousand USD | -73.09% |
| 2016 Q3 | 177.63 Thousand USD | 149.66% |
| 2016 Q4 | 266.29 Thousand USD | 49.91% |
| 2016 FY | 641.55 Thousand USD | -75.41% |
| 2016 Q2 | 71.14 Thousand USD | -43.75% |
| 2015 Q1 | 1.57 Million USD | -4.34% |
| 2015 FY | 2.6 Million USD | 20.1% |
| 2015 Q4 | 469.94 Thousand USD | 16.12% |
| 2015 Q3 | 404.7 Thousand USD | 157.01% |
| 2015 Q2 | 157.46 Thousand USD | -90.01% |
| 2014 Q2 | 198.5 Thousand USD | -21.47% |
| 2014 Q4 | 1.64 Million USD | 2165.77% |
| 2014 Q3 | 72.73 Thousand USD | -63.36% |
| 2014 FY | 2.17 Million USD | 64.57% |
| 2014 Q1 | 252.77 Thousand USD | -30.01% |
| 2013 Q2 | 87.35 Thousand USD | 118.09% |
| 2013 Q1 | 40.05 Thousand USD | -49.97% |
| 2013 Q4 | 361.16 Thousand USD | -56.55% |
| 2013 Q3 | 831.19 Thousand USD | 851.56% |
| 2013 FY | 1.31 Million USD | 537.51% |
| 2012 Q3 | 40 Thousand USD | -4.2% |
| 2012 FY | 207.01 Thousand USD | -84.29% |
| 2012 Q4 | 80.05 Thousand USD | 100.1% |
| 2012 Q2 | 41.75 Thousand USD | -7.62% |
| 2012 Q1 | 45.2 Thousand USD | -86.63% |
| 2011 Q3 | 190.25 Thousand USD | -19.92% |
| 2011 FY | 1.31 Million USD | -50.23% |
| 2011 Q1 | 551.6 Thousand USD | 102.32% |
| 2011 Q2 | 237.56 Thousand USD | -56.93% |
| 2011 Q4 | 337.98 Thousand USD | 77.65% |
| 2010 Q4 | 272.64 Thousand USD | -74.07% |
| 2010 Q3 | 1.05 Million USD | -12.27% |
| 2010 Q2 | 1.19 Million USD | 860.52% |
| 2010 Q1 | 124.76 Thousand USD | -34.21% |
| 2010 FY | 2.64 Million USD | 392.89% |
| 2009 Q1 | 80.76 Thousand USD | -17.63% |
| 2009 FY | 537.05 Thousand USD | 88.52% |
| 2009 Q4 | 189.63 Thousand USD | 179.58% |
| 2009 Q3 | 67.82 Thousand USD | -48.51% |
| 2009 Q2 | 131.73 Thousand USD | 63.11% |
| 2008 Q4 | 98.04 Thousand USD | -23.15% |
| 2008 Q2 | 26.45 Thousand USD | -2.92% |
| 2008 Q3 | 127.57 Thousand USD | 382.34% |
| 2008 Q1 | 27.24 Thousand USD | -26.39% |
| 2008 FY | 284.87 Thousand USD | 24.8% |
| 2007 Q2 | 70.16 Thousand USD | -10.79% |
| 2007 FY | 228.26 Thousand USD | 19.41% |
| 2007 Q3 | 55.38 Thousand USD | -21.06% |
| 2007 Q1 | 78.65 Thousand USD | 74.03% |
| 2007 Q4 | 37.01 Thousand USD | -33.18% |
| 2006 Q1 | 20.95 Thousand USD | 184.95% |
| 2006 Q3 | 61.71 Thousand USD | -2.25% |
| 2006 Q4 | 45.19 Thousand USD | -26.77% |
| 2006 FY | 191.16 Thousand USD | 1133.21% |
| 2006 Q2 | 63.13 Thousand USD | 201.22% |
| 2005 Q4 | 7355.00 USD | 45.3% |
| 2005 Q3 | 5062.00 USD | 0.0% |
| 2005 FY | 15.5 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | 15.255% |
| Ansell Limited | 495.5 Million USD | 99.51% |
| Ansell Limited | 495.5 Million USD | 99.51% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | 97.07% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -40.201% |
| Psykey, Inc. | 1.21 Million USD | -99.965% |
| ConvaTec Group Plc | 910.31 Million USD | 99.733% |
| ConvaTec Group Plc | 872.5 Million USD | 99.722% |
| Encision Inc. | 3.77 Million USD | 35.751% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -1611.108% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -2107.329% |
| Innovative MedTech Inc. | 6.09 Million USD | 60.214% |
| LifePoint, Inc. | 7.42 Million USD | 67.314% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | 61.781% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -183.806% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -234.172% |
| Reflect Scientific, Inc. | 1.06 Million USD | -128.123% |
| SmileDirectClub, Inc. | 517 Million USD | 99.531% |
| Sector 10, Inc. | 39.84 Thousand USD | -5990.099% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 99.963% |
| SheerVision, Inc. | 2.33 Million USD | -4.07% |
| Vasamed, Inc. | 4.67 Million USD | 48.072% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | 5.28% |
| Yubo International Biotech Limited | 1.25 Million USD | -92.908% |